About: BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an OMNI-EGFR inhibitor in clinical development for advanced EGFR-mutant non-small cell lung cancer (NSCLC), BH-501284, and BH-30236, a macrocyclic CLK (Cdc2-like kinase) inhibitor being evaluated in patients with relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndrome (HR-MDS). BlossomHill Therapeutics, Inc. was incorporated in 2020 and is based in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $16.61 (-3.93%)
BLSM NASDAQ BlossomHill Therapeutics, Inc. Common Stock
BlossomHill Therapeutics, Inc. Common Stock share price
BLSM price activity
Last Price
$16.610
Change (24hr)
-0.68 USD (-3.93%)
Volume
251.28K
Volume (4w avg)
-
Open
$17.17
Day Range
$16.12 - $17.67
Previous Close
$17.29
Last Trade
07 Oct, 8:00 pm GMT+0
Delayed
07 Oct, 8:00 pm GMT+0
BLSM price performance
Delayed
07 Oct, 8:00 pm GMT+0
BLSM Market Signals